CNX Coal Resources Maintains Dividend

CNX Coal Resources Maintains Dividend

CNX Coal Resources, a master limited partnership formed by CONSOL Energy (CNX), said it will maintain its quarterly cash distribution $0.51 per common unit. The company’s board has also approved a full cash distribution of approximately $1.9 million to holders of convertible Class A preferred units. The distributions will be made Feb. 15 to shareholders as of Feb. 9. CNX meanwhile said it plans to file a universal shelf registration […]

Read More ˃
ARI Network Services Says Toro Renews Partnership

ARI Network Services Says Toro Renews Partnership

ARI Network Services said Tuesday that The Toro Company, a player in the outdoor power equipment industry, renewed its partnership with ARI to act as the only co-op approved website vendor for its network of residential and landscape contractor equipment dealers throughout North America. Shares of ARI fell over 2%, still trading near the top end of their 52-week price range of $3.50 – $5.59. Toro stock climbed less than […]

Read More ˃
Late Bounce Lifts Tech Stocks

Late Bounce Lifts Tech Stocks

Technology stocks were edging higher during late Monday trading, reversing narrow losses earlier today and shares of tech companies in the S&P 500 rising about 0.1%. In company news, Perion Network (PERI) was holding on to a moderate gain late Monday after the software firm today said it has selected Doron Gerstel as its new CEO, effective April 2. Perion will be the fifth company Gerstel has led as chief […]

Read More ˃
AIG Partners with Berkshire Hathaway Unit

AIG Partners with Berkshire Hathaway Unit

American International Group has entered into an adverse development reinsurance agreement with National Indemnity Company (NICO), a subsidiary of Berkshire Hathaway. The agreement, effective January 1, 2016, covers 80% of substantially all of AIG’s US Commercial long-tail exposures for accident years 2015 and prior, which includes the largest part of AIG’s US casualty exposures during that period, a statement published on AIG’s website on Friday showed. Under the terms of […]

Read More ˃
Allergan Gets FDA OK on Topical Treatment For Facial Erythema

Allergan Gets FDA OK on Topical Treatment For Facial Erythema

Allergan shares were up 1% pre-market Thursday after the drugmaker said the Food and Drug Administration approved Rhofade cream, a topical treament for persistent facial erythema (redness) associated with rosacea in adults. Persistent facial redness is described as the most common sign of rosacea, which may resemble a sunburn that does not go away. Approval of the treatment was based on two clinical studies which showed that once-daily treatment with […]

Read More ˃